Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Mrtx1719
2. 2630904-44-6
3. Benzonitrile, 2-(4-(4-(aminomethyl)-1,2-dihydro-1-oxo-6-phthalazinyl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-(cyclopropyloxy)-3-fluoro-, (2s)-
4. (m)-27
5. 2-[4-[4-(aminomethyl)-1-oxo-2h-phthalazin-6-yl]-2-methylpyrazol-3-yl]-4-chloro-6-cyclopropyloxy-3-fluorobenzonitrile
6. 2-(4-(4-(aminomethyl)-1-oxo-2h-phthalazin-6-yl)-2-methylpyrazol-3-yl)-4-chloro-6-cyclopropyloxy-3-fluorobenzonitrile
7. Refchem:201848
8. Mrtx 1719
9. Prmt5-mta Inhibitor Mrtx1719
10. Prmt5-mta Complex Inhibitor Mrtx1719
11. Mta-cooperative Prmt5 Inhibitor Mrtx1719
12. 2630904-45-7
13. (s)-mrtx-1719
14. Navlimetostat
15. Ay4a8wd6js
16. Unii-ay4a8wd6js
17. (2r)-2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile
18. 2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile
19. 2629314-96-9
20. Benzonitrile, 2-(4-(4-(aminomethyl)-1,2-dihydro-1-oxo-6-phthalazinyl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-(cyclopropyloxy)-3-fluoro-, (2r)-
21. Benzonitrile, 2-[4-[4-(aminomethyl)-1,2-dihydro-1-oxo-6-phthalazinyl]-1-methyl-1h-pyrazol-5-yl]-4-chloro-6-(cyclopropyloxy)-3-fluoro-, (2r)-
22. Navlimetostat [inn]
23. Mrtx1719 Racemate
24. Mrtx1719 Hcl
25. Uhn5pkm648
26. C23h18clfn6o2
27. Mrtx-1719 Hcl
28. Orb1303284
29. Chembl5075255
30. Schembl23087302
31. Schembl29735316
32. Ex-a5505a
33. Ex-a5505b
34. Gtpl12116
35. Wlz3536
36. Glxc-25300
37. Mrtx-1719?
38. Ex-a5505
39. Mfcd34604075
40. Nsc840578
41. Nsc841295
42. Akos040757913
43. Hy-139611b
44. Nsc-840578
45. Nsc-841295
46. Ac-36984
47. Da-69270
48. Da-75760
49. Ms-28566
50. Sy310874
51. Hy-139611
52. Cs-0226219
53. Cs-0343422
54. F78345
55. (2m)-2-(4-(4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl)-1-methyl-1h-pyrazol-5-yl)-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile
56. 2-[4-[4-(aminomethyl)-1-oxo-1,2-dihydrophthalazin-6-yl]-1-methyl-5-pyrazolyl]-4-chloro-6-cyclopropoxy-3-fluorobenzonitrile
57. 2-[4-[4-(aminomethyl)-1-oxo-2h-phthalazin-6-yl]-2-methyl-pyrazol-3-yl]-4-chloro-6-(cyclopropoxy)-3-fluoro-benzonitrile
58. Benzonitrile, 2-[4-[4-(aminomethyl)-1,2-dihydro-1-oxo-6-phthalazinyl]-1-methyl-1h-pyrazol-5-yl]-4-chloro-6-(cyclopropyloxy)-3-fluoro-
| Molecular Weight | 464.9 g/mol |
|---|---|
| Molecular Formula | C23H18ClFN6O2 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 118 |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 846 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
78
PharmaCompass offers a list of Mrtx-1719 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Mrtx-1719 manufacturer or Mrtx-1719 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mrtx-1719 manufacturer or Mrtx-1719 supplier.
A MRTX 1719 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of MRTX 1719, including repackagers and relabelers. The FDA regulates MRTX 1719 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. MRTX 1719 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A MRTX 1719 supplier is an individual or a company that provides MRTX 1719 active pharmaceutical ingredient (API) or MRTX 1719 finished formulations upon request. The MRTX 1719 suppliers may include MRTX 1719 API manufacturers, exporters, distributors and traders.
MRTX 1719 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of MRTX 1719 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right MRTX 1719 GMP manufacturer or MRTX 1719 GMP API supplier for your needs.
A MRTX 1719 CoA (Certificate of Analysis) is a formal document that attests to MRTX 1719's compliance with MRTX 1719 specifications and serves as a tool for batch-level quality control.
MRTX 1719 CoA mostly includes findings from lab analyses of a specific batch. For each MRTX 1719 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
MRTX 1719 may be tested according to a variety of international standards, such as European Pharmacopoeia (MRTX 1719 EP), MRTX 1719 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (MRTX 1719 USP).